首页> 外文期刊>Mechanisms of Ageing and Development >Human XPF controls TRF2 and telomere length maintenance through distinctive mechanisms.
【24h】

Human XPF controls TRF2 and telomere length maintenance through distinctive mechanisms.

机译:人类XPF通过独特的机制控制TRF2和端粒的长度维持。

获取原文
获取原文并翻译 | 示例
           

摘要

XPF-ERCC1, a structure-specific endonuclease, is involved in nucleotide excision repair, crosslink repair and homologous recombination. XPF-ERCC1 is also found to interact with TRF2, a duplex telomeric DNA binding protein. We have previously shown that XPF-ERCC1 is required for TRF2-promoted telomere shortening. However, whether XPF-ERCC1 by itself has a role in telomere length maintenance has not been determined. Here we report that overexpression of XPF induces telomere shortening in XPF-proficient cells whereas XPF complementation suppresses telomere lengthening in XPF-deficient cells. These results suggest that XPF-ERCC1 can function as a negative mediator of telomere length maintenance. In addition, we find that introduction of wild type XPF into XPF-deficient cells leads to over 40% reduction in TRF2 association with telomeric DNA, indicating that XPF-ERCC1 negatively regulates TRF2 binding to telomeric DNA. Furthermore, we show that XPF carrying mutations in the conserved nuclease domain fails to control TRF2 association with telomeric DNA but it is competent for modulating telomere length maintenance. These results imply that XPF-ERCC1 controls TRF2 and telomere length maintenance through two distinctive mechanisms, with the former requiring its nuclease activity. Our results further imply that TRF2 association with telomeres may be deregulated in cells derived from XPF patients.
机译:XPF-ERCC1是一种结构特异性核酸内切酶,参与核苷酸切除修复,交联修复和同源重组。还发现XPF-ERCC1与TRF2(一种双链端粒DNA结合蛋白)相互作用。先前我们已经证明,TRF2促进端粒缩短需要XPF-ERCC1。但是,尚未确定XPF-ERCC1本身是否在端粒长度维持中起作用。在这里我们报道XPF的过表达在XPF熟练的细胞中诱导端粒缩短,而XPF互补在XPF缺乏的细胞中抑制端粒延长。这些结果表明,XPF-ERCC1可以作为端粒长度维持的负调节剂。此外,我们发现将野生型XPF引入XPF缺陷细胞会导致TRF2与端粒DNA缔合减少40%以上,这表明XPF-ERCC1负调控TRF2与端粒DNA的结合。此外,我们表明在保守的核酸酶结构域中携带突变的XPF无法控制TRF2与端粒DNA的缔合,但能够调节端粒的长度。这些结果表明,XPF-ERCC1通过两种独特的机制控制TRF2和端粒长度的维持,前者需要其核酸酶活性。我们的结果进一步暗示,在来自XPF患者的细胞中,TRF2与端粒的缔合可能被失调。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号